Literature DB >> 32750460

Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration.

Dongliang Zhang1, Lan Jiang1, Mengling Wang2, Meiping Jin2, Xuemei Zhang2, Difa Liu3, Zhangwei Wang3, Licai Yang4, Xudong Xu5.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Berberine is generally extracted from Rhizoma Coptidis (Coptis chinensis Franch), a traditional Chinese medicine, which can be used in the treatment of intestinal diseases, respiratory infections and cardiovascular diseases. Berberine is especially effective for the treatment of gastrointestinal disorders such as diarrhea because of the effect of heat-clearing and detoxifying in traditional Chinese medicine theory. AIM OF THE STUDY: This study aimed to examine the protective effect of berberine (BBR) on the damaged colonic epithelial barrier caused by peritoneal dialysis fluid (PDF).
METHODS: The damage to intestinal epithelial barrier was examined by intraperitoneally injecting 4.25% dextrose-containing PDF in mice and establishing a long-term PD model in rats with renal failure. Then, the therapeutic potential of berberine on PD-related colonic injuries was examined. T84 colonic epithelial cells were used to test the effect of PDF and berberine in vitro. The damaging effect of PDF and the protective effect of berberine were evaluated by histology staining, histofluorescence and transmission electron microscopy. The migration of colonic epithelial cell and actin-related protein 2 (Arp2) were tested by wound healing assay and Western blot to determine the possible mechanism in vitro.
RESULTS: PD administration induced intestinal epithelial barrier dysfunction in the colon, and berberine alleviated the injury by increasing the tight junction and adhesion junction protein, both in vivo and in vitro. Berberine could also improve the morphology of microvillus. In the wound healing assay, berberine exhibited the ability to promote cell migration, indicating that berberine could probably recover the function of intestinal epithelial cells when the intestinal epithelial barrier was damaged by the PDF.
CONCLUSIONS: The present study demonstrates that berberine can ameliorate intestinal epithelial barrier dysfunction in the colon caused by long-term PDF through improving cell migration.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Actin-related protein 2; Berberine; Cell migration; Intestinal epithelial barrier; Peritoneal dialysis fluid

Mesh:

Substances:

Year:  2020        PMID: 32750460     DOI: 10.1016/j.jep.2020.113206

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Astragaloside IV Alleviates Intestinal Barrier Dysfunction via the AKT-GSK3β-β-Catenin Pathway in Peritoneal Dialysis.

Authors:  Jiaqi He; Mengling Wang; Licai Yang; Hong Xin; Fan Bian; Gengru Jiang; Xuemei Zhang
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

Review 2.  Anti-Hyperglycemic Agents in the Adjuvant Treatment of Sepsis: Improving Intestinal Barrier Function.

Authors:  Yi-Feng Wang; Jia-Wei Li; Da-Peng Wang; Ke Jin; Jiao-Jie Hui; Hong-Yang Xu
Journal:  Drug Des Devel Ther       Date:  2022-06-04       Impact factor: 4.319

3.  Evaluation of berberine efficacy in reducing the effects of aflatoxin B1 and ochratoxin A added to male broiler rations.

Authors:  Pouyan Malekinezhad; Laura E Ellestad; Nazar Afzali; Seyed Homayoun Farhangfar; Arash Omidi; Abbas Mohammadi
Journal:  Poult Sci       Date:  2020-11-05       Impact factor: 3.352

4.  Berberine Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis and Inhibits the Secretion of Gut Lysozyme via Promoting Autophagy.

Authors:  Xiaofan Xu; Wei Li; Zhendong Yu; Le Zhang; Ting Duo; Ya Zhao; Wenxia Qin; Wenbo Yang; Libao Ma
Journal:  Metabolites       Date:  2022-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.